Browse history interactively

Page 1

Page 1Revision 1

Page 2

Page 2Revision 2

← Previous editContent deleted Content addedVisualWikitext

Revision as of 10:50, 23 June 2011 edit84.56.152.174 (talk)No edit summary← Previous edit		Latest revision as of 23:33, 22 July 2024 edit undoCitation bot (talk | contribs)Bots5,429,198 edits Added bibcode. | Use this bot. Report bugs. | Suggested by Graeme Bartlett | #UCB_toolbar
(55 intermediate revisions by 37 users not shown)
Line 1:		Line 1:
	{{chembox		{{chembox
			| Verifiedfields = changed
	| verifiedrevid = 401953240
			| Watchedfields = changed
	|ImageFile=Chlorfenviphos is.svg
			| verifiedrevid = 435792707
	|ImageSize=200px
			| ImageFile=Chlorfenvinphos Structures V.1.svg
	|IUPACName=Phosphoric acid diethyl ester
			| ImageSize=350px
	|OtherNames=Birlane, Dermaton, Sapercon, Steladone, Supona
			| ImageAlt=Skeletal formulas of (E)-chlorfenvinphos (left) and (Z)-chlorfenvinphos (right)
	|Section1= {{Chembox Identifiers
			| ImageFile1 = Chlorfenvinphos 3D spacefill.png
	| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
			| ImageAlt1 = Space-filling model of the (Z)-chlorfenvinphos molecule
			| IUPACName = diethyl phosphate
			| OtherNames=Clofenvinfos; Chlorfenvinfos; Chlorphenvinfos; Chlofenvinphos; Chlofenvinfos; Vinylphate; Apachlor; Birlane; Dermaton; Enolofos; Haptarax; Haptasol; Dermaton; Sapercon; Steladone; Supona
			|Section1={{Chembox Identifiers
			| CASNo = 470-90-6
			| CASNo_Ref = {{cascite|correct|CAS}}
			| CASNo_Comment = (''EZ'')
			| CASNo1 = 18708-86-6
			| CASNo1_Ref = {{cascite|correct|CAS}}
			| CASNo1_Comment = (''E'')
			| CASNo2 = 18708-87-7
			| CASNo2_Ref = {{cascite|correct|CAS}}
			| CASNo2_Comment = (''Z'')
			| ChEMBL = 2104653
			| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
	| ChemSpiderID = 4526760		| ChemSpiderID = 4526760
			| KEGG = C18654
			| RTECS = TB8750000
			| UNNumber = 3018
	| UNII_Ref = {{fdacite|correct|FDA}}		| UNII_Ref = {{fdacite|correct|FDA}}
	| UNII = F2G9XS1W91		| UNII = F2G9XS1W91
			| UNII1_Ref = {{fdacite|correct|FDA}}
			| UNII1 = WO4EMF0QD6
			| UNII1_Comment = (''E'')
			| UNII2_Ref = {{fdacite|correct|FDA}}
			| UNII2 = 871L5HXP4D
			| UNII2_Comment = (''Z'')
			| EINECS = 207-432-0
	| InChI = 1/C12H14Cl3O4P/c1-3-17-20(16,18-4-2)19-12(8-13)10-6-5-9(14)7-11(10)15/h5-8H,3-4H2,1-2H3/b12-8-		| InChI = 1/C12H14Cl3O4P/c1-3-17-20(16,18-4-2)19-12(8-13)10-6-5-9(14)7-11(10)15/h5-8H,3-4H2,1-2H3/b12-8-
	| InChIKey = FSAVDKDHPDSCTO-WQLSENKSBC		| InChIKey = FSAVDKDHPDSCTO-WQLSENKSBC
Line 16:		Line 41:
	| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}		| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
	| StdInChIKey = FSAVDKDHPDSCTO-WQLSENKSSA-N		| StdInChIKey = FSAVDKDHPDSCTO-WQLSENKSSA-N
			| PubChem = 5377784
	| CASNo_Ref = {{cascite|correct|CAS}}
			| SMILES = Clc1cc(Cl)ccc1C(OP(=O)(OCC)OCC)=Cl
	| CASNo=470-90-6
	| PubChem = 5377784
	| SMILES = Clc1cc(Cl)ccc1C(OP(=O)(OCC)OCC)=Cl
	}}		}}
	|Section2= {{Chembox Properties		|Section2={{Chembox Properties
	| Formula=C<sub>12</sub>H<sub>14</sub>Cl<sub>3</sub>O<sub>4</sub>P		| C=12 | H=14 | Cl=3 | O=4 | P=1
			| Appearance=Amber liquid
	| MolarMass=359.57 g/mol
			| Density=
	| Appearance=Amber liquid
	| Density=		| MeltingPt=
	| MeltingPt=		| BoilingPt=
			| Solubility=145 mg/L
	| BoilingPt=
	| Solubility=145 mg/L
	}}		}}
	|Section3= {{Chembox Hazards		|Section3={{Chembox Hazards
			| NFPA-H = 4
	| MainHazards=
	| FlashPt=		| NFPA-R = 0
			| NFPA-F = 1
	| Autoignition=
			| NFPA-S =
			| MainHazards=
			| FlashPt=
			| AutoignitionPt =
			| LD50 = 15 &nbsp;mg/kg (rat, oral)
			| GHS_ref=<ref>{{cite web |title=Clofenvinfos |url=https://pubchem.ncbi.nlm.nih.gov/compound/5377784#section=Safety-and-Hazards |website=pubchem.ncbi.nlm.nih.gov |language=en}}</ref>
			| GHSPictograms = {{GHS06}}{{GHS09}}
			| GHSSignalWord = Danger
			| HPhrases = {{H-phrases|300|311|330|410}}
			| PPhrases = {{P-phrases|260|262|264|270|271|273|280|284|301+316|302+352|304+340|316|320|321|330|361+364|391|403+233|405|501}}
	}}		}}
	}}		}}
	'''Chlorfenvinphos''' is an ] that was widely used as an ] but has been banned in several countries. It is a colorless solid, but for commercial purposes, it was marketed as an ] liquid. Its use in the U.S. was cancelled in 1991. Chlorfenvinphos was sold under several brand names.<ref name=Ullmann>Robert L. Metcalf “Insect Control” in Ullmann’s Encyclopedia of Industrial Chemistry” Wiley-VCH, Weinheim, 2002. {{DOI|10.1002/14356007.a14_263}}</ref>		'''Chlorfenvinphos''' is an ] that was widely used as an ] and an ].<ref name="een">{{PubChem|10107}}</ref> The molecule itself can be described as an ] ester derived from dichloroacetophenone and diethylphosphonic acid. Chlorfenvinphos has been included in many products since its first use in 1963. However, because of its toxic effect as a ] it has been banned in several countries, including the United States and the European Union. Its use in the United States was discontinued in 1991.<ref name="twee"></ref>
			The pure chemical is a colorless solid, but for commercial purposes, it is often marketed as an ] liquid. The insecticides, mostly used in liquid form, contain between 50% and 90% chlorfenvinphos. The substance easily mixes with ], ], and ]. Furthermore, chlorfenvinphos is ] to metal and ] in the environment.<ref name="drie"></ref>
	The molecule can be described as an ] ester derived from dichloro] and diethylphosphonic acid. The molecule ] in the environment.
			It is classified as an ] in the United States as defined in Section 302 of the U.S. ] (42 U.S.C. 11002), and is subject to strict reporting requirements by facilities which produce, store, or use it in significant quantities.<ref name="gov-right-know">{{Cite journal | publisher = ] | title = 40 C.F.R.: Appendix A to Part 355—The List of Extremely Hazardous Substances and Their Threshold Planning Quantities | url = http://edocket.access.gpo.gov/cfr_2008/julqtr/pdf/40cfr355AppA.pdf | edition = July 1, 2008 | access-date = October 29, 2011 | archive-url = https://web.archive.org/web/20120225051612/http://edocket.access.gpo.gov/cfr_2008/julqtr/pdf/40cfr355AppA.pdf | archive-date = February 25, 2012 | url-status = dead }}</ref>
	==Safety==
	The substance has harmful effects on the ].<ref>Chlorfenvinphos summary from U.S. Agency for Toxic Substances and Disease Registry</ref> The {{LD50}} is 15 &nbsp;mg/kg (rats, oral).
			==Pesticide use==
			===History===
			Dermaton was the first registered product containing chlorfenvinphos. It was introduced in the United States in 1963 and was used as an insecticide and acaricide for controlling ] and ] on domestic pets and other animals. Between 1963 and 1970, additional uses were registered, including the use as ], surface spray and ]. Because of these effects, chlorfenvinphos was often used on farms to control adult flies in dairy barns, milk rooms, poultry houses and yards, and in other animal buildings. Furthermore, it was used to control ] flies in manure storage pits and piles and other refuse accumulation areas around dairies and feedlots.<ref name="twee"/> In the early 1980s, chlorfenvinphos was registered for additional uses in a dust formulation for use in dog kennels and in dog collars for the control of fleas and ticks.<ref name="zeven"></ref>
			Outside the United States, chlorfenvinphos, registered under the trade names Birlane, C8949, CGA 26351, Sapecron, Steladone and Supona, was used as a soil insecticide for controlling root maggots, root worms and ]. Chlorfenvinphos was also used against Colorado beetles on potatoes and scale insects and mite eggs on citrus. Furthermore, the compound had the same uses as in the United States.
			There is no quantitative information on the total volume of chlorfenvinphos really used as a ] in the United States or elsewhere. Since all uses of the chemical in the United States were canceled in 1991, use is likely to have declined, although there are no data showing this trend.
			===Regulation and advisories===
			No international regulations exist for the use of chlorfenvinphos, although standards and guidelines have been set to protect people from the possible harmful effects of the ]. No regulation exists for ], but multiple minimal risk levels (MRL) have been estimated for oral exposure. These data have been developed from lowest observed adverse effect levels (LOAEL) in test rats, based on adverse neurological effects. The acute oral MRL has been established at 0.002&nbsp;mg/kg/day, while the chronic MRL has been established somewhat lower, at 0.0007&nbsp;mg/kg/day.
			Furthermore, chlorfenvinphos is one of the chemicals regulated under “The Emergency Planning and Community Right-to-Know act of 1986”. This means that owners and operators of certain facilities that manufacture, import, process or otherwise use the chemical, are obligated to report their annual release of the chemical to any environmental media.<ref name="drie"/>
			However, the use of chlorfenvinphos has now been banned in the European Union and in the United States. In Europe it is banned as a plant protection product. An exception is Switzerland, where chlorfenvinphos is still allowed for use in crops and certain vegetables under the brand name Birlane. In Australia, chlorfenvinphos is partially banned. Thus, it was withdrawn in alfalfa, potatoes and mushrooms, while it is still used in ] for combating ectoparasites until 2013.<ref name="acht"></ref>
			==Production==
			Chlorfenvinphos was first introduced in the United States in 1963, by the ] International Chemical Company Ltd., Ciba AG (now Ciba-Geigy AG) and by ]. Its main use was as an insecticide and acaricide used to control insect pests on livestock and household pests such as flies, fleas, and mites.<ref name="vier"></ref> Since its first application, many manufacturers included chlorfenvinphos in their products. Some common trade names are Birlane, Dermaton, Sapercon, Steladone, and Supona.<ref name="drie"/> Since 1991, however, information on current production of chlorfenvinphos has been conflicting. One source lists base producers of the compound as the ].<ref name="vier"/> However, no producers of chlorfenvinphos were identified in a 1993 Directory of Chemical Producers for the United States of America.<ref name="vijf"></ref> Moreover, there have been no registered uses for this compound as a pesticide in the United States since 1995.<ref name="twee"/>
			Chlorfenvinphos is produced by reaction of ] (P(OEt)3) with 2,2,2'',4''-tetrachloro acetophenone (C8H4Cl4O). In the production process, both the Z and E isomers are formed in a ratio (Z:E) of 8.5:1. The technical grade material therefore contains over 92% chlorfenvinphos.<ref name="zes"></ref>
			Unfortunately, no data is available in the ] (TRI) database on total environment releases of this compound from facilities. This is mainly because chlorfenvinphos was not considered a dangerous toxin until the early 1990s. Therefore, chlorfenvinphos is not one of the compounds about which facilities were required to report to the Toxic Release Inventory.<ref name="zeven"/>
			==Toxicokinetics==
			Chlorfenvinphos is most commonly absorbed into the body through either ingestion of food products that have been treated with the pesticide, or through dermal absorption, though the latter is much less efficient.
			Once absorbed, chlorfenvinphos is widely distributed throughout the body, and has been detected in a variety of bodily fluids.<ref name="negen"></ref> However, as an organophosphorus compound, it does not accumulate well in tissues.
			The first and most important step of metabolism of chlorfenvinphos in humans is accomplished by the enzyme ] in liver microsomes. This enzyme facilitates oxidative dealkylation of the compound to ] and 2-chloro-1-(2,4-dichlorophenyl) vinylethylhydrogen phosphate, the latter of which quickly breaks down to ]. Acetophenone is then reduced to an alcohol and conjugated by glutathione transferases.,<ref name="tien">{{cite journal | last1 = Hutson | first1 = D | last2 = Akintonwa | first2 = D | last3 = Hathway | first3 = D | year = 1967 | title = The Metabolism of 2-Chloro-1-(2',4'-dichlorophenyl)vinylDiethyl Phosphate (Chlorfenvinphos) in the Dog and Rat | journal = Biochem. J. | volume = 133 | page = 102 }}</ref><ref name="elf">{{cite journal | last1 = Hutson | first1 = DH | last2 = Wright | first2 = AS | year = 1980 | title = The effect of hepatic microsomal monooxygenase induction on the metabolism and toxicity of the organophosphorus insecticide chlorfenvinphos | journal = Chem Biol Interact | volume = 31 | issue = 1| pages = 93–101 | doi=10.1016/0009-2797(80)90142-8| pmid = 7389007 | bibcode = 1980CBI....31...93H }}</ref>
			Excretion of chlorfenvinphos is fairly rapid. In rats, an administered dose is excreted in 4 days, mostly in urine.<ref name="twaalf">{{cite journal | last1 = Barna | first1 = J | last2 = Simon | first2 = G | year = 1973 | title = Effect of small oral doses of Birlane (chlorfenvinphos) on intestinal resorption | journal = Kiserl Orvostud | volume = 26 | issue = 6| pages = 605–609 }}</ref>
			==Mechanism of toxicity==
			The toxicity of chlorfenvinphos is primarily caused by its inhibition of ] activity. Chlorfenvinphos reacts with the ] binding sites of enzymes that hydrolyze acetylcholine, thereby preventing their catalysis of this reaction. The reaction itself is a ], which is reversible. The phosphorylated enzymes can undergo conformational changes and additional reactions however, which prevent the dephosphorylation. This “aging” results in irreversible inhibition of the cholinesterase.<ref name="drie"/>
			Acetylcholine is a ] in the nervous system, it targets ] and ] and receptors in the central nervous system. These receptors are used to pass on an action potential across the synaptic cleft between neurons. Inhibition of ] enzymes results in the accumulation of acetylcholine at its receptors. This leads to continuous or excessive stimulation of neurons that respond to acetylcholine. ] poisoning leads to different symptoms, depending on the part of the nervous system that is affected. The most likely cause of death in chlorfenvinphos is ] due to ] and ].<ref name="drie"/>
			==Toxicity==
			===Toxic effects===
			The toxic effects of accumulation of acetylcholine can be divided into three categories, based upon its actions in different parts of the nervous system. Muscarinic receptors that respond to acetylcholine are found in smooth muscles, the heart and ]. The muscarinic symptoms of cholinergic poisoning are therefore tightness in the chest, wheezing due to bronchoconstriction, ], ], increased salivation, lacrimation and sweating and increased ], which leads to nausea, vomiting and diarrhea.
			Nicotinic receptors responding to acetylcholine can be found in skeletal muscle and the ]. The nicotinic symptoms of cholinergic poisoning are therefore fatigue, involuntary twitching, muscular weakness, ] and ].
			Symptoms of accumulation of acetylcholine in the central nervous system are diverse and include tension, anxiety, ], convulsions, depression of the respiratory and circulatory centers and coma.<ref name="dertien"></ref>
			===Acute toxicity===
			The acute toxicity of chlorfenvinphos varies widely between species. Oral LD50 values range from 9.6–39&nbsp;mg/kg in rats to >12,000&nbsp;mg/kg in dogs.<ref name="veertien"></ref>
			Though no direct data on the acute toxicity in humans is available, an ''in vitro'' study of the ] of chlorfenvinphos has shown that human liver enzymes were almost as effective as those of rabbits, who have an oral LD50 of 412-4,700&nbsp;mg/kg.,<ref name="veertien"/><ref name="vijftien">{{cite journal | last1 = Hutson | first1 = D.H. | last2 = Logan | first2 = C.J. | year = 1986 | title = Detoxification of the organophosphorus insecticide chlorfenvinphos by rat, rabbit and human liver enzymes | journal = Xenobiotica | volume = 16 | issue = 1 | pages = 87–93 | doi=10.3109/00498258609043509| pmid = 3946099 }}</ref>
			===Long-term toxicity===
			Prolonged exposure to chlorfenvinphos has been observed to decrease plasma and erythrocyte cholinesterase activity in humans.<ref name="zestien"></ref> No significant genotoxicity, ] or ] has been reported. On the basis of a NOAEL of 0.05&nbsp;mg/kg observed in rats, an acceptable daily intake for humans of 0.0005&nbsp;mg/kg has been established.<ref name="zeventien"></ref>
			==Biomarkers==
			===Biomarkers of exposure===
			Traces of unchanged chlorfenvinphos and its polar metabolites can be detected in animals, which have been exposed to chlorfenvinphos. These small amounts can be used to prove that chlorfenvinphos exposure has occurred and the method of analysis is non-invasive.
			Another method to assess chlorfenvinphos exposure is to measure the activity of cholinesterases in the blood. Two pools of cholinesterases exist in the blood: acetylcholinesterase in erythrocytes and pseudocholinesterase in plasma. The acetylcholinesterase in erythrocytes is identical to the acetylcholinesterase found in neuromuscular tissue. The function of plasma pseudocholinesterase is unknown, but its activity is considered to be a more sensitive ] for organophosphate exposure than erythrocyte cholinesterase activity. The inhibition of the individual cholinesterases or the inhibition of their combined activity can be used as a marker of exposure. However, cholinesterase inhibition is caused by all anticholinesterase compounds and is therefore not a specific biomarker for chlorfenvinphos. In addition, the activity of cholinesterases in the blood varies in populations and there are no studies which have measured a correlation between chlorfenvinphos exposure and cholinesterase inhibition. There have been suggestions that chlorfenvinphos or its metabolites would be a better biomarker of exposure than its cholinesterase activity inhibition.<ref name="zestien"/>
			===Biomarkers of effect===
			In combination with analysis of reductions in cholinesterase activity in the blood, symptoms of organophosphate poisoning can be used to identify victims of organophosphate poisoning. These symptoms are not specific for chlorfenvinphos, but for anticholinesterase compounds in general.<ref name="zestien"/>
			==Treatments of exposure==
			{{main article|Organophosphate poisoning}}
			Ingestion of chlorfenvinphos, either by accident or through suicidal intent, can be treated as with other acute organophosphate poisonings. This includes a combination of three approaches:<ref name="marrs_1993">{{cite journal|last1=Marrs|first1=Timothy C.|title=Organophosphate poisoning|journal=Pharmacology & Therapeutics|date=January 1993|volume=58|issue=1|pages=51–66|doi=10.1016/0163-7258(93)90066-M|pmid=8415873 }}</ref><ref name="antonijevic_2007">{{cite journal|last1=Antonijevic|first1=B.|last2=Stojiljkovic|first2=M. P.|title=Unequal Efficacy of Pyridinium Oximes in Acute Organophosphate Poisoning|journal=Clinical Medicine & Research|date=1 March 2007|volume=5|issue=1|pages=71–82|doi=10.3121/cmr.2007.701|pmid=17456837|pmc=1855336}}</ref><ref name="king_2015">{{cite journal|last1=King|first1=Andrew M.|last2=Aaron|first2=Cynthia K.|title=Organophosphate and Carbamate Poisoning|journal=Emergency Medicine Clinics of North America|date=February 2015|volume=33|issue=1|pages=133–151|doi=10.1016/j.emc.2014.09.010|pmid=25455666}}</ref>
			# Administration of an ] such as ], considered an ];
			# Administration of a cholinesterase reactivator, in the pyridinium oxime family, usually ];
			# Administration of ]s, e.g. ]s (of which ] is most effective).
			The efficacy of oxime treatment is controversial.<ref name=king_2015 /> Ingestion of organophosphates as residues on food rarely reaches clinically relevant doses.<ref name=marrs_1993 />
	==References==		==References==
Line 48:		Line 151:
	==External links==		==External links==
	*		*
	{{insecticides}}
	{{Cholinergics}}
			{{Insecticides}}
			{{Acetylcholine metabolism and transport modulators}}
			{{Xenobiotic-sensing receptor modulators}}
			]
	]		]
	]
	]		]
			]
			]
	]
	]